A precision-formulated triple peptide blend combining GHK-Cu, BPC-157, and TB-500 — three of the most extensively studied peptides in preclinical research.
The three compounds are studied for overlapping activity in extracellular-matrix and cell-signalling pathways. Each compound is independently HPLC verified, with a batch-specific COA included.







Reviews
There are no reviews yet.